OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 129 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2014. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $103,000 | -12.7% | 240,880 | +15.0% | 0.00% | – |
| Q1 2016 | $118,000 | -78.5% | 209,377 | -34.5% | 0.00% | – |
| Q4 2015 | $550,000 | -53.1% | 319,880 | -42.4% | 0.00% | – |
| Q3 2015 | $1,172,000 | -88.6% | 555,492 | -73.2% | 0.00% | -100.0% |
| Q2 2015 | $10,254,000 | -34.8% | 2,071,603 | +3.1% | 0.00% | -40.0% |
| Q1 2015 | $15,737,000 | +39.2% | 2,009,810 | +7.7% | 0.01% | +25.0% |
| Q4 2014 | $11,305,000 | +3.2% | 1,865,540 | -27.5% | 0.00% | +33.3% |
| Q3 2014 | $10,959,000 | -46.3% | 2,572,569 | -22.1% | 0.00% | -50.0% |
| Q2 2014 | $20,406,000 | -7.0% | 3,302,056 | -2.2% | 0.01% | -25.0% |
| Q1 2014 | $21,948,000 | +5.4% | 3,376,331 | -8.7% | 0.01% | +14.3% |
| Q4 2013 | $20,831,000 | +0.0% | 3,700,083 | +8.9% | 0.01% | -12.5% |
| Q3 2013 | $20,828,000 | +6.1% | 3,397,512 | +1.2% | 0.01% | 0.0% |
| Q2 2013 | $19,622,000 | – | 3,357,117 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |